Syndax Pharmaceuticals Inc (SNDX): Net Income
-$285.42M
Year ended 2025-12-31
-$220.76M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$285.42M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$318.76M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$209.36M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$149.34M | n/m | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $24.93M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$73.16M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$56.05M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$73.96M | n/m | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | -$60.80M | n/m | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | -$44.47M | n/m | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | -$24.12M | n/m | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | -$19.83M | n/a | 2017-03-14, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$285.42M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$221.25M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $78.30M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $5.07M | -48.3% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | -$6.88M | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$130.77M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$68.92M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$196.54M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$20.20M | n/m |
Compare SNDX, PHAT, CYRX, LFVN side by side · Screen every company in Pharmaceutical Preparations ↗